Comparison of the monocyte-to-HDL cholesterol ratio between patients with STEMI and NSTEMI: A retrospective observational study

• Principais autores: Abdullah Algın (Autor), Serdar Özdemir (Autor)
• Formato: Livro
• Publicado em: National Scientific Medical Center, 2021-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.
• Notes: 1812-2892; 2313-1519; 10.23950/jcmk/11326
• Keywords: atherosclerosis; coronary artery disease; high-density lipoprotein cholesterol; monocyte count; Internal medicine; RC31-1245; Specialties of internal medicine; RC581-951
• Source: Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 18, Iss 6, Pp 45-49 (2021)

<b>Introduction </b><br /> This study sought to compare patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in terms of the monocyte-to-HDL cholesterol ratio.<br /> <b>Materials and Methods</b><br /> A total of 79 patients with non-ST-segment elevation myocardial infarction and 30 patients with 30 ST-segment elevation myocardial infarction were included in the study. Demographics, comorbidities, smoking status, medical history, and initial laboratory findings were retrospectively noted from the hospital computer-based patient data system.<br /> <b>Results</b><br /> Significant differences were detected between the ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction groups in relation to the neutrophil count [7.27 (6.05-9.05) versus 5.41 (4.26-7.21), p<0.001] and mean platelet volume [9.4 (8.8-10) versus 8.6 (7.3-9.5), p=0.002]. There was no statistically significant difference between the two groups in the term of the monocyte-to-HDL cholesterol ratio [0.016 (0.012-0.021) versus 0.016 (0.011-0.024), p=0.757, Bonferroni-corrected p value: 0.0033)].<br /> <b>Conclusion</b><br /> Based on the results of our study, the monocyte-to-HDL cholesterol ratio did not significantly differ between the patients with ST-segment elevation myocardial infarction and those with non-ST-segment elevation myocardial infarction.